Literature DB >> 1313027

Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin.

S Sato1, R C Hughes.   

Abstract

The carbohydrate binding specificity of Mr = 30,000 lectin (CBP30) from baby hamster kidney (BHK) cells has been studied by inhibition of binding of the radiolabeled lectin to asialofetuin-Sepharose using model oligosaccharides and glycopeptides. CBP30 binds type I or II Gal beta(1----3(4))GlcNAc chains but not Gal(beta 1----3)GalNAc. The inhibitory potency of straight chain polylactosamine structures or complex-type branched glycans is increased in proportion to the number of Gal(beta 1----3(4)) units present. Fucosylation or sialylation of terminal galactose residues or further substitution by (alpha 1----3)-linked galactose or N-acetylgalactosamine does not affect binding whereas substitution of the penultimate N-acetylglucosamine residue drastically reduces binding. Thus, blood group A, H type I or H type II structures, shows high affinity whereas Lex, Lea, and Leb structures bind poorly. CBP30 binds to murine Engelbreth-Holm-Swarm (EHS) tumor laminin and human amniotic fluid fibronectin but not human plasma fibronectin. Binding involves polylactosamine glycans as well as tri- and tetraantennary complex-type glycans present in EHS laminin and amniotic fluid fibronectin but absent in plasma fibronectin. Proteolytic fragments of EHS laminin (E1X/Nd, P1, E8, and E3) bind CBP30, but only fragment E8 supports attachment and spreading of BHK cells. BHK cell adhesion to EHS laminin or fragment E8 was not disturbed by CBP30-specific antibodies, but at relatively high concentrations (45 micrograms/ml) CBP30 inhibited spreading and partially attachment of cells on laminin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313027

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Kinetic measurements of binding of galectin 3 to a laminin substratum.

Authors:  E A Barboni; S Bawumia; R C Hughes
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

2.  So what do your sugars do?

Authors:  R C Hughes
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 3.  Galectins in parasite infection and allergic inflammation.

Authors:  Anna R Young; Els N Meeusen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 4.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

5.  Inhibitory action of a new lectin from Xerocomus chrysenteron on cell-substrate adhesion.

Authors:  Claire Marty-Detraves; Frédéric Francis; Laurent Baricault; Didier Fournier; Laurent Paquereau
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

6.  Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.

Authors:  D K Hsu; R Y Yang; Z Pan; L Yu; D R Salomon; W P Fung-Leung; F T Liu
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

7.  Cell type-dependent alterations of binding of synthetic blood group antigen-related oligosaccharides in lung cancer.

Authors:  K Kayser; N V Bovin; T V Zemlyanukhina; S Donaldo-Jacinto; J Koopmann; H J Gabius
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

8.  Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.

Authors:  Malathy P V Shekhar; Pratima Nangia-Makker; Larry Tait; Fred Miller; Avraham Raz
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma.

Authors:  Riaz I Zuberi; Daniel K Hsu; Omer Kalayci; Huan-Yuan Chen; Holly K Sheldon; Lan Yu; John R Apgar; Toshiaki Kawakami; Craig M Lilly; Fu-Tong Liu
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Expression of the endogenous 14-kDa beta-galactoside-binding lectin galectin in normal human skin.

Authors:  Y Akimoto; J Hirabayashi; K Kasai; H Hirano
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.